Trump suggests Pfizer could win US Covid-19 vaccine approval, JNJ to come later
Trump also cited efforts by Moderna Inc and AstraZeneca Plc
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters
US President Donald Trump on Monday suggested Pfizer Inc could secure the first US approval of a Covid-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.
Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later."
He also cited efforts by Moderna Inc and AstraZeneca Plc.
